Zimmer Biomet Holdings, Inc. (ZBH) to Issue Quarterly Dividend of $0.24 on January 30th

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announced a quarterly dividend on Wednesday, December 17th. Shareholders of record on Tuesday, December 30th will be given a dividend of 0.24 per share by the medical equipment provider on Friday, January 30th. This represents a c) dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Tuesday, December 30th.

Zimmer Biomet has a payout ratio of 11.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Zimmer Biomet to earn $8.87 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.8%.

Zimmer Biomet Stock Performance

Zimmer Biomet stock opened at $90.78 on Friday. The company has a market cap of $17.99 billion, a price-to-earnings ratio of 22.47, a price-to-earnings-growth ratio of 2.39 and a beta of 0.61. Zimmer Biomet has a 12 month low of $85.33 and a 12 month high of $114.44. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.43 and a quick ratio of 1.39. The stock’s 50-day moving average is $94.07 and its 200-day moving average is $96.58.

Zimmer Biomet (NYSE:ZBH) last issued its earnings results on Wednesday, November 5th. The medical equipment provider reported $1.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.88 by $0.02. Zimmer Biomet had a return on equity of 12.85% and a net margin of 10.05%.The business had revenue of $2 billion during the quarter, compared to analysts’ expectations of $2.01 billion. During the same quarter in the previous year, the business earned $1.74 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. Zimmer Biomet has set its FY 2025 guidance at 8.100-8.300 EPS. Equities analysts anticipate that Zimmer Biomet will post 8.22 earnings per share for the current year.

Institutional Investors Weigh In On Zimmer Biomet

A number of hedge funds have recently bought and sold shares of the business. Brighton Jones LLC purchased a new position in shares of Zimmer Biomet during the 4th quarter valued at approximately $204,000. Wellington Management Group LLP boosted its stake in Zimmer Biomet by 230.6% during the 1st quarter. Wellington Management Group LLP now owns 36,865 shares of the medical equipment provider’s stock valued at $4,172,000 after acquiring an additional 25,713 shares during the last quarter. Vident Advisory LLC grew its holdings in Zimmer Biomet by 101.6% during the 1st quarter. Vident Advisory LLC now owns 14,088 shares of the medical equipment provider’s stock worth $1,595,000 after acquiring an additional 7,099 shares in the last quarter. Baird Financial Group Inc. increased its position in shares of Zimmer Biomet by 12.9% in the 1st quarter. Baird Financial Group Inc. now owns 51,982 shares of the medical equipment provider’s stock worth $5,883,000 after purchasing an additional 5,957 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. acquired a new stake in shares of Zimmer Biomet in the 1st quarter valued at about $289,000. Institutional investors and hedge funds own 88.89% of the company’s stock.

About Zimmer Biomet

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.